StonvexLoading…
StonvexCore line items from PNW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.34B | $5.12B | $4.70B | $4.32B |
Operating Income | $1.07B | $1.01B | $824.64M | $731.91M |
Net Income | $631.64M | $626.03M | $518.78M | $500.83M |
EPS (Diluted) | $5.05 | $5.24 | $4.41 | $4.26 |
Total Assets | $30.03B | $26.10B | $24.66B | $22.72B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.60M | $3.84M | $4.96M | $4.83M |
Free Cash Flow OCF − CapEx | $-819.52M | $-639.37M | $-638.67M | $-466.05M |
Shares Outstanding | 121.97M | 116.23M | 113.80M | 113.42M |